Matthew Boyd
Net worth: 12 975 $ as of 30/06/2026
Net worth: 12 975 $ as of 30/06/2026
Matthew Boyd is Chief Regulatory Officer at enGene Therapeutics, Inc. starting in 2025.
Formerly, Mr. Boyd was Vice President-Regulatory Affairs at Albireo Pharma, Inc. and Head-Regulatory Affairs & Quality Assurance at Zambon Usa Ltd. Education includes an undergraduate degree from Philadelphia College of Pharmacy and an MBA from Kelley School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/06/2026 | 7,500 ( 0.01% ) | 12 975 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| ENGENE THERAPEUTICS INC. | General Counsel | 01/09/2024 |
| Companies | Position | End |
|---|---|---|
| ALBIREO PHARMA, INC. | General Counsel | - |
Zambon Usa Ltd.
Zambon Usa Ltd. Pharmaceuticals: OtherHealth Technology Zambon Usa Ltd. is an American company. The company is located in the US. | General Counsel | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philadelphia College of Pharmacy
Philadelphia College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Zambon Usa Ltd.
Zambon Usa Ltd. Pharmaceuticals: OtherHealth Technology Zambon Usa Ltd. is an American company. The company is located in the US. | Health Technology |
enGene Holdings, Inc.
enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions